Current Assets Cambiamento Data
Almirall EUR 762.27M 209.56M 2023-06
AstraZeneca USD 22.5B 338M 2023-09
Bayer EUR 37.53B 1.25B 2023-09
Genmab DKK 33.03B 3.28B 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
GRIFOLS EUR 6.45B 1.44B 2023-12
Hikma Pharmaceutical USD 2.18B 177M 2023-06
Lonza CHF 5.62B 92M 2023-06
Recordati EUR 1.22B 225.67M 2023-09
Roche Holding CHF 30.98B 2.84B 2023-06
Smith & Nephew USD 3.88B 22M 2023-06
UCB EUR 3B 303M 2023-06



GlaxoSmithKline Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.